The leaves and stems of Perilla frutescens var. acuta Kudo (PF) have been used to prevent threatened abortion in traditional medicine in the East Asian countries. Because reduced receptivity of endometrium is a cause of abortion, we analyzed the action of PF on the endometrial receptivity. PF increased the level of leukemia inhibitory factor (LIF), a major cytokine regulating endometrial receptivity, and LIF receptor in human endometrial Ishikawa cells. The PF-induced LIF expression was mediated by c-jun N-terminal kinase (JNK) and p38 pathways. Adhesion between Ishikawa cells and trophoblastic JAr cells stimulated by PF treatment was abolished by knock down of LIF expression or antagonism of LIFR. In addition, the expressions of integrin b3 and b5 were increased by PF treatment in Ishikawa cells. The PF-induced expression of integrin b3 and b5 was reduced with an LIFR antagonist. Neutralization of both integrins successfully blocked PF-stimulated adhesion of JAr cells and Ishikawa cells. These results suggest that PF enhanced the adhesion between Ishikawa cells and JAr cells by increasing the expression of integrin b3 and b5 via an LIF-dependent pathway. Given the importance of endometrial receptivity in successful pregnancy, PF can be a novel and effective candidate for improving pregnancy rate.
Introduction
In spite of the development of diverse assisted reproduction technologies (ARTs), including in vitro fertilization, prevention of incomplete embryo implantation remains a major unmet need (1) . To solve the problem of embryo implantation, it is crucial to enhance endometrial receptivity toward a properly developed embryo (2) . It is well known that diverse biomolecules, such as cytokines and growth factors, play important roles in the process of developing a receptive endometrium (3) . Among them, several previous studies have shown that leukemia inhibitory factor (LIF), a member of interleukin-6 family of cytokines, is one of the major factors that regulates endometrial receptivity (4) . In addition, LIF expression defects have been shown to be involved in multiple implantations failures in patients with female infertility (5) . Therefore, research has focused on developing novel candidates that stimulate embryo implantation rates by enhancing LIF expression, especially by using natural herbal medicines or traditional therapy, including acupuncture (6e8).
The leaves and stems of Perilla frutescens var. acuta Kudo (Labiatae family), a perennial herb, has being used in traditional medicine of East Asian countries for treating symptoms of the common cold, including shivering fits, fever, chest pains, and cough, and for preventing threatened abortion (9) . In addition, previous pharmacological studies have shown that P. frutescens has anti-inflammatory and anti-tumor effects (10, 11) . However, there are no reports available on the effects of P. frutescens on enhancing endometrial receptivity or pregnancy rate. Because reduced endometrial receptivity is a cause of abortion in early stage of pregnancy (12) , we predicted that PF may be involved in the regulation of endometrial receptivity.
In this study, we investigated the effect of P. frutescens on the expression of LIF and adhesion between trophoblast and endometrium in vitro. The expression of adhesion molecules, including integrins involved in PF-induced endometrial receptivity was also examined.
Materials and methods

Materials
Antibodies against LIF, LIFR, phospho-extracellular signal-regulated kinases (ERK) 1/2, ERK2, p38, integrin aV, b3, and b5, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and b-actin were purchased from Santa Cruz Biotechnology (Dallas, TX). Antibodies against phospho-c-Jun N-terminal kinases (JNK) and phospho-p38 were purchased from Cell signaling (Danver, MA, USA), and the antibody for JNK was purchased from SigmaeAldrich (St. Louis, MO, USA). Specific inhibitors against signaling pathways, including U0126 (inhibitor for mitogen-extracellular signal-regulated kinase/extracellular signal-regulated kinase; MEK/ERK), SB203580 (inhibitor for p38), and SP600125 (inhibitor for JNK) were obtained from Merck Millipore (Billerica, MA, USA). Recombinant antagonists for human LIFR (hLA) expressed in Escherichia coli were prepared as described previously (13).
Plant material and extract preparation
The leaves and stems of P. frutescens were purchased from Omniherb Co. (Daegu, Korea). The plant was collected in Gyeongsangbuk-do Province, Republic of Korea in 2013, and identified by a botanical expert working at Omniherb Co. A boucher specimen (KMRC-DC-H21) was deposited at the Healthy Aging Korean Medicine Research Center, Pusan National University. The sample was extracted as previously described (14) . Briefly, the leaves and stems of P. frutescens (100 g) were extracted with distilled water (1 L) for 2 h at 100 C, and then centrifuged at 4000 rpm for 10 min. The supernatant was extracted with 70% ethanol for polysaccharide precipitation at 4 C. After centrifugation at 4000 rpm for 10 min, the supernatant was evaporated and lyophilized by freeze-drier to give a powder (abbreviated as PF, 7.856 g). PF was freshly dissolved in dimethyl sulfoxide (SigmaeAldrich) before experiments.
Fingerprinting high-performance liquid chromatography (HPLC) analysis
Phytochemical characteristics of PF were identified by HPLC analysis as previously described (9, 15) , with some modifications. HPLC analysis was performed using an Agilent 1200 series system (Agilent Technologies, Santa Clara, CA, USA) and LC solution software (version 1.24) was used for data analysis. AkzoNobel KR100-5C18 column (AkzoNobel, Amsterdam, Netherlands;
4.6 Â 250 mm; pore size, 3.5 mm) was used as an analytical column. 
Cell culture
The human endometrial Ishikawa cell line was generously provided by Dr. Jacques Simard (CHUL Research Center, Quebec, Canada) and human trophoblastic JAr cells were provided from the Korean Cell Line Bank (Seoul, Korea). Ishikawa cells were cultured as monolayers at 37 C in an atmosphere containing 5% CO 2 /air and Dulbecco's Modified Eagle Medium (DMEM; Welgene, Daegu, Korea) with 10% heat-inactivated fetal bovine serum (FBS; SigmaeAldrich) and 1% penicillin/streptomycin (Gibco, Carlsbad, CA, USA). JAr cells were cultured as monolayers at 37 C in an atmosphere containing 5% CO 2 /air and Roswell Park Memorial Institute 1640 (RPMI1640; Welgene) containing 10% heat-inactivated FBS and 1% penicillin/streptomycin.
Cell viability assay
Ishikawa cells were cultured in 24-well plates with the indicated concentrations of PF in serum free medium for 24 h. Next, the medium was replaced with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (2 mg/mL) and incubated at 37 C in a cell culture incubator for 3 h. The formazan crystals formed by MTT reduction were dissolved with DMSO and EtOH solution and measured at 540 nm with a microplate reader (SpectraMax M2, Molecular Devices, Sunnyvale, CA, USA).
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated from Ishikawa cells using GeneJET RNA Purification Kit (Thermo Fischer Scientific, Waltham, MA, USA). Total RNA of each sample was subjected to reverse transcription with oligo-dT primers by using M-MLV reverse transcriptase (Enzynomics, Daejeon, Korea). The cDNA was amplified by PCR using DiaStarTM Taq DNA Polymerase (Solgent Co., Daejeon, Korea).
The primers and PCR conditions used for amplifying LIF, b-actin, ITGAV, ITGB3, and ITGB5 are shown in Table 1 . The amplified DNA was separated by electrophoresis in 1% agarose gels containing ethidium bromide and visualized under ultraviolet (UV) light. The images were acquired with the GelDoc-It TS Imaging System (UVP, Upland, CA, USA).
Western blot analysis
Total proteins were isolated from Ishikawa cells. Equal amount of proteins (25 mg) were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred to nitrocellulose membranes (Bio-Rad Laboratories, Hercules, CA, USA). The membranes were blocked in 5% skim milk in Tris-buffered saline (TBS) and then incubated with each antibody for target proteins, including LIF, LIFR, phospho-ERK1/2, ERK2, phospho-p38, p38, phospho-JNK, JNK, integrin aV, integrin b3, integrin b5, GAPDH, and b-actin, overnight. Membranes were then washed in TBS and incubated with appropriate secondary antibodies conjugated with the horseradish peroxide. The signals were visualized by using the enhanced chemiluminescence system (GE Healthcare, Piscataway, NJ, USA). 
Adhesion assay
Knockdown of LIF by short hairpin RNA (shRNA)
To knockdown hLIF expression, five different shRNA clones were purchased from Open Biosystems (Thermo Scientific). The lentiviral vector encoding shRNA (3 mg) was transfected in 293T cells by using Lipofectamine 2000 (Invitrogen). After 48 h, supernatants harboring lentiviruses were collected and infected into Ishikawa cells. The cells were subjected to selection with 3 mg/mL puromycin (SigmaeAldrich) for 1 week. The knockdown efficiency of the shRNAs against LIF expression was checked by western blot analysis.
Statistical analysis
The data from experiments were indicated as the value of percentage compared to the control and expressed as the mean ± standard deviation (SD). The differences between the mean values of 2 groups were determined by student t-test and multicomparisons between groups were analyzed using one-way analysis of variance (ANOVA) with a Turkey's post-hoc test using GraphPad Prism (GraphPad Software, La Jolla, CA, USA). The minimum significance level was set at a p-value of 0.05. All experiments were performed at least three times, independently.
Results
HPLC analysis and cytotoxic effect of PF on Ishikawa cells
As shown in Fig. 1A , the PF used in this study seems to be identical to the previously reported PF standard (9, 15) . To determine the optimal concentration, the cytotoxic effect of PF on Ishikawa cells was determined. PF did not show significant cytotoxicity up to a concentration of 50 mg/mL (Fig. 1B) . Thus, for subsequent studies, 50 mg/mL was established as the optimum working concentration.
PF increased the attachment of JAr onto Ishikawa cells and the expression of LIF and LIFR
To examine the possibility that PF affects implantation of a human embryo onto the endometrium, we performed an in vitro adhesion assay using human trophoblastic JAr cells and endometrial Ishikawa cells. Adhesion between Ishikawa cells and, JAr cells Table 1 Primers used for PCR of LIF, integrins, and b-actin. was increased about 2 fold in PF treated cells compared to control ( Fig. 2A) , indicating that PF has a positive effect on the adhesion between JAr cells and Ishikawa cells. Because the function of LIF and the LIFR pathway is crucial in embryo implantation process (16), we checked the expression level of LIF and LIFR. Result from western blot and RT-PCR analyses clearly demonstrated that the levels of LIF and LIFR were increased by PF treatment in a dose-dependent manner (Fig. 2B and C) .
PF regulates LIF expression through activating p38 and JNK
Several previous studies have found that the expression of LIF was regulated by MAP kinase signaling pathways (17, 18) . Therefore, we examined if activation of ERK, JNK, and p38 pathway is involved in PF-induced expression of LIF. The results showed that PF treatment activated p38 and ERK from 2 h. The JNK was activated after 2 h from treatment of PF (Fig. 3A) . In addition, phosphorylation of ERK, JNK, and p38 were increased in a dose-dependent fashion (Fig. 3B) . To confirm which of these signaling pathways regulated LIF expression, we used specific inhibitors for each of these signaling molecules, such as SP600125 for JNK, SB203580 for p38, and U0126 for MEK/ERK. The results of RT-PCR and western blot analysis clearly indicate that treatment of SP600125 and SB202580 significantly blocked the PF-induced stimulation of LIF expression (Fig. 3C ). In addition, as shown in Fig. S1 PF-induced increase in LIFR expression was mediated by JNK, p38, and ERK pathways.
PF augments adhesion of JAr cells to Ishikawa cells through the LIF/LIFR axis
To demonstrate whether ligandereceptor interaction of LIF/LIFR axis plays an important role in PF-induced adhesion between JAr and Ishikawa cells, we performed the adhesion assay using knocking down of LIF expression by shRNA transfection and antagonizing LIFR by hLA treatment. We found that knocking down LIF expression in Ishikawa cells abrogated PF-stimulated adhesion between JAr and Ishikawa cells (Fig. 4A) . In addition, pretreatment with hLA reduced PF-induced adhesion of JAr cells onto Ishikawa cells (Fig. 4B) .
LIF-dependent expression of integrin b3 and b5 is crucial for the adhesion of trophoblast on endometrial cells
The expressions of adhesion molecules including integrins, plays an important roles in the regulation of endometrial receptivity toward properly developed embryos (19, 20) . To evaluate which integrins are involved in PF-induced adhesion of trophoblast on endometrial cells, we examined the expression of integrin aV, b3, and b5. We found that the expression of integrin b3 and b5 was increased by PF treatment. The expression of integrin aV was not changed by PF treatment. The PF-stimulated expression of integrin b3 and b5 was reduced by suppression of LIFR function using hLA ( Fig. 5A and B) . The results demonstrated that PF regulates the expression of integrin b3 and b5 in an LIF-dependent manner. We next examined whether the expressions of integrin b3 and b5 plays a crucial role in PF-enhanced endometrial receptivity toward trophoblast. The treatment of neutralization antibodies against these integrins blocked PF-stimulated attachment of JAr cells onto Ishikawa cells (Fig. 5C) . Thus, we concluded that PFinduced expression of integrin b3 and b5 plays a key role in the stimulation of endometrial receptivity.
Discussion
Traditional medicine has been used to treat female infertility, and progressively increased efforts have been made to provide evidence that supports its use (7, 8, 21) . Diverse cytokines and growth factors, such as interleukin-1, epidermal growth factor (EGF), calcitonin, amphiregulin, heparin binding-EGF, colony stimulating factor-1, trophinin/tastin, and LIF, are involved in embryo implantation (22) . Among them, LIF in particular is regarded as a major factor that regulates endometrial receptivity, because genetic abolishment or functional suppression of LIF impairs embryo implantation (23, 24) . Thus, we focused on the expression of LIF as part of our ongoing efforts to identify novel agents that enhance embryo implantation and improve pregnancy rates. Here, we demonstrated that PF increases the expression of LIF and improves endometrial receptivity toward trophoblastic cells in vitro.
As there is no standard drug in use that enhances endometrial receptivity, we were not able to compare our results to reference drug. However, from this point of view, we believe that treatment with PF is a promising strategy for overcoming infertility due to implantation failure.
A well-established in vitro model has been used to investigate endometrial receptivity of several human cell lines with, diverse characteristics (25) . The Ishikawa cell line, a welldifferentiated human endometrial adenocarcinoma, was established by Dr. Nishida in 1980, and it has since been used to or with the indicated concentration of PF for 2 h (B). The phosphorylation of signal molecules was examined by western blot analysis. Band intensity was calculated by fold of control and shown as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001 in comparison with control group (1st lane) (C) Ishikawa cells were pretreated with 5 mM of specific inhibitors for JNK (SP600125), p38 (SB203580) or ERK (U0126). After 1 h, the cells were treated with PF (50 mg/mL) for 24 h. The protein and mRNA expression levels of LIF were estimated by Western blot analysis and RT-PCR, respectively. The expression of b-actin was used as the internal control. The intensities of bands were calculated by fold of control and shown as mean ± SD of three independent experiments. ***p < 0.001 in comparison with control group (1st lane) and ###p < 0.001 in comparison with PF-treated group (2nd lane).
evaluate both glandular and luminal functions of the endometrium (26) . JAr cells, a choriocarcinoma cell line, also have been used as trophoblastic cells to examine embryo implantation (27) . Thus, in this study, we chose to use these cells for investigating the expression of LIF and for evaluating endometrial receptivity.
The results clearly showed that PF increases in a dose dependent manner, the expression of not only LIF but also LIFR (Fig. 2) . Few studies have examined the regulation of LIF expression. The induction of LIF by IL-1b is mediated by the MEK/ERK and nuclear factor kappa B (NF-kB) pathway in normal articular human chondrocytes (28) . In addition, it is known that the p38 MAPK signaling pathway is activated upstream of LIF-dependent neuroprotection (18) . Therefore, we determined which of these pathways were involved in PF-induced expression of LIF. The NF-kB pathway was not activated by PF treatment (data not shown). Although all of the MAPK pathways, including ERK, JNK, and p38, were activated by PF, only the JNK and p38 pathways were involved in the PF-stimulated expression of LIF (Fig. 3) . Furthermore, the PF-induced expression of LIFR was regulated by JNK, p38, and ERK pathways (Fig. S1 ). These data suggested that PF regulated the expression of LIF and LIFR expressions via different signaling pathways. Knocking down LIF expression or blocking LIFR function decreased the adhesion between trophoblastic JAr cells and endometrial Ishikawa cells (Fig. 4) . These results clearly demonstrate that PF-induced endometrial receptivity was directly mediated by increased expression of LIF and by the function of LIFR.
For successful embryo implantation, the interaction between LIF and LIFR must activate the signal transducer and activator of transcription 3 (STAT3), which consequently enhances the expression of adhesion molecules, such as integrin aVb3 and aVb5 (29) . In addition, integrin aVb3 and aVb5 have the motif for cellecell adhesion that act as receptors for the arginine-glycineaspartic acid (RGD) domain which is essential in embryo implantation (29, 30) . Our results also revealed that PF treatment increased the expression of integrin b3 and integrin b5, but the expression of integrin aV was not changed. Treatment with hLA revealed that the expression of integrin b3 and b5 was mediated by LIF expression. Furthermore, inhibition of integrin b3 and b5 using neutralizing antibodies successfully blocked the PF-induced adhesion between JAr and Ishikawa cells (Fig. 5) . We previously demonstrated that the expression of integrin b3 and b5 are crucial for the LIF-mediated adhesion of trophoblast and endometrial cells (29) . These findings suggest that PF enhances endometrial receptivity through the expression of integrin b3 and b5 in an LIF-dependent manner (Fig. 6) . Major causes of female infertility, such as the problems with ovulation, fertilization, fertilized egg development, and embryo transport, were improved by the development of ARTs (31) . However, the imperfection of implantation was not solved by ARTs or other medications, and it remains an unmet need clinically. Thus, several studies using therapeutic manipulation of traditional medicine, such as acupuncture and herbal remedies, were performed to improve implantation rates (7, 8) . Based on results from these studies and ours, herbal medicines can be a good alternative option for increasing endometrial receptivity. Additional extensive studies are necessary to identify the active compounds of PF, from the known ingredients of PF, such as protocatechuic acid, ferulic acid, rosmarinic acid, and coumaric acid, or unknown compounds. In addition, it is also needed to establish the in vivo efficacy of PF.
In conclusion, PF induced the expression of LIF and LIFR through JNK and p38 signaling pathways in endometrium Ishikawa cells. In addition, PF-induced LIF expression increased the attachment of trophoblastic JAr cells to endometrial Ishikawa cells. This adhesion was mediated by the expression of integrin b5 and b3. Taken together, our results suggest that PF is a promising candidate for the development of novel and effective medicines to help female patients suffering from a defect in implantation.
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